4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-23-021209
Chief Strategy & Dev. Officer sold 120,000 shares at an average $28.70 ($3,444,290)
- Chief Strategy & Dev. Officer acquired 120,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Desai Veeral · Chief Strategy & Dev. Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-23 | Exercise or conversion : show line 1 in the form | +22,710 | $3.00 | $68,130 | 299,439 | D |
| 2023-03-23 | Sale : show line 2 in the form | −22,710 | $28.71 | $651,911 | 276,729 | D |
| 2023-03-24 | Exercise or conversion : show line 3 in the form | +97,290 | $3.00 | $291,870 | 374,019 | D |
| 2023-03-24 | Sale : show line 4 in the form | −97,290 | $28.70 | $2,792,379 | 276,729 | D |
| Open-market sales · 120,000 sh · avg $28.70 · $3,444,290 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-03-23 | Exercise or conversion : show line 5 in the form Options (Rights to Buy) | −22,710 | 1,617,290 | D |
| 2023-03-24 | Exercise or conversion : show line 6 in the form Options (Rights to Buy) | −97,290 | 1,520,000 | D |
Loading xslF345X04/doc4.xml…